Physician profile
Tim R Ridder
NPI 1790752574
$3,928.42
in general payments reported to CMS, 2019-2025
16 companies · $357 in 2025
The $357 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $660 · 2020: $298 · 2021: $341 · 2022: $707 · 2023: $772 · 2024: $793 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,923.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,922.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $698.98 | 2021-2024 | |
| Alcon Vision LLC | $645.05 | 2019-2023 | Clareon |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $467.74 | 2019-2021 | |
| Coopervision INC. | $466.46 | 2022-2025 | Myday Contact Lens, Cvi Contact Lens |
| Sun Pharmaceutical Industries INC. | $415.68 | 2022-2025 | |
| Johnson & Johnson Vision Care, INC. | $298.21 | 2019-2024 | Acuvue |
| Bausch & Lomb Americas INC. | $259.48 | 2022-2024 | Infuse, Xiidra, Miebo |
| Abbvie INC. | $122.55 | 2025 | |
| Astellas Pharma US INC | $120.94 | 2023 | |
| Sight Sciences, INC. | $108.10 | 2025 | Tearcare System |
| Alcon Research LLC | $104.71 | 2019 | |
| Novartis Pharmaceuticals Corporation | $93.17 | 2019 | |
| Ivantis, INC | $67.79 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $23.24 | 2025 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $22.24 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $14.08 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tim Ridder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.